Sclerosing Agent [EPC]

Sclerosing Agent [EPC] was reported 450 times

Drugs of the Sclerosing Agent [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 SARS-COV-1 TEST 1 0.5000
1 CEREBRAL GAS EMBOLISM 3 0.1875
2 DECREASED NASOLABIAL FOLD 1 0.0556
3 PHLEBITIS DEEP 2 0.0270
4 PACEMAKER GENERATED ARRHYTHMIA 1 0.0263
5 BLEPHAROCHALASIS 1 0.0200
6 PARADOXICAL EMBOLISM 2 0.0187
7 NECROBIOSIS LIPOIDICA DIABETICORUM 1 0.0159
8 ELECTROCARDIOGRAM ST-T SEGMENT DEPRESSION 1 0.0154
9 MALFORMATION VENOUS 1 0.0143
10 TEMPERATURE DIFFERENCE OF EXTREMITIES 1 0.0141
11 OXALOSIS 1 0.0132
12 ANGIODERMATITIS 1 0.0118
13 PINGUECULA 1 0.0094
14 POLIOMYELITIS 1 0.0093
15 ADMINISTRATION SITE DISCOLOURATION 1 0.0080
16 HAEMOSIDERIN STAIN 1 0.0078
17 VESSEL PERFORATION 1 0.0076
18 VAGINAL FLATULENCE 2 0.0066
19 SPINAL CORD ISCHAEMIA 1 0.0066
20 INJECTION SITE THROMBOSIS 2 0.0061
21 POST PROCEDURAL CONTUSION 2 0.0061
22 APPLICATION SITE WOUND 1 0.0061
23 VASCULAR PROCEDURE COMPLICATION 1 0.0058
24 GRANULOMATOUS LYMPHADENITIS 1 0.0053
25 BREAST INDURATION 1 0.0052
26 CHEST WALL ABSCESS 1 0.0051
27 UNINTENTIONAL USE FOR UNAPPROVED INDICATION 3 0.0050
28 NEOVASCULARISATION 1 0.0038
29 BLEEDING VARICOSE VEIN 2 0.0037
30 PRODUCT IMPURITY 1 0.0036
31 LYMPHOCYTIC HYPOPHYSITIS 1 0.0036
32 COR PULMONALE ACUTE 1 0.0036
33 SUPERFICIAL VEIN THROMBOSIS 3 0.0036
34 RETINOPATHY HYPERTENSIVE 1 0.0033
35 INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM 1 0.0033
36 BREAST INFLAMMATION 1 0.0032
37 INJECTION SITE ULCER 3 0.0032
38 SOFT TISSUE NECROSIS 2 0.0029
39 SYNOVIAL RUPTURE 1 0.0029
40 PORTAL VENOUS GAS 1 0.0028
41 XANTHOPSIA 1 0.0027
42 SPINAL CORD OEDEMA 1 0.0027
43 PITYRIASIS ROSEA 1 0.0027
44 BLUE TOE SYNDROME 1 0.0026
45 TRANSIENT TACHYPNOEA OF THE NEWBORN 1 0.0025
46 EMBOLIA CUTIS MEDICAMENTOSA 2 0.0025
47 ALLERGIC GRANULOMATOUS ANGIITIS 2 0.0024
48 ANAL SPHINCTER ATONY 1 0.0023
49 PHONOPHOBIA 1 0.0022
50 NECROSIS ISCHAEMIC 1 0.0022
51 VEIN DISCOLOURATION 1 0.0021
52 ANAPHYLACTOID SHOCK 1 0.0021
53 LACRIMATION DECREASED 1 0.0021
54 IMMUNODEFICIENCY COMMON VARIABLE 1 0.0020
55 SENSORIMOTOR DISORDER 1 0.0020
56 ADMINISTRATION SITE EXTRAVASATION 2 0.0020
57 PALMOPLANTAR PUSTULOSIS 1 0.0019
58 PRESBYOPIA 1 0.0018
59 HAEMORRHAGIC OVARIAN CYST 1 0.0017
60 PERIPHERAL EMBOLISM 2 0.0017
61 SKIN NECROSIS 9 0.0017
62 HYPERBILIRUBINAEMIA NEONATAL 1 0.0017
63 NEPHROCALCINOSIS 2 0.0017
64 BLOOD IMMUNOGLOBULIN M INCREASED 1 0.0016
65 ARTERIAL THROMBOSIS 3 0.0016
66 INJECTION SITE NECROSIS 3 0.0015
67 APPLICATION SITE ULCER 1 0.0014
68 INJECTION SITE HYPOAESTHESIA 2 0.0014
69 SYSTEMIC SCLERODERMA 1 0.0014
70 HEMIANOPIA HOMONYMOUS 1 0.0014
71 GRANULOMA ANNULARE 1 0.0014
72 RETINAL VASCULAR OCCLUSION 1 0.0014
73 BLISTER RUPTURE 1 0.0013
74 SKIN NEOPLASM EXCISION 1 0.0013
75 MICROANGIOPATHIC HAEMOLYTIC ANAEMIA 1 0.0013
76 ENTEROCOCCAL SEPSIS 1 0.0012
77 FEMALE GENITAL TRACT FISTULA 2 0.0012
78 INJECTION SITE OEDEMA 2 0.0012
79 PHARYNGEAL HYPOAESTHESIA 1 0.0011
80 INJECTION SITE SCAB 1 0.0010
81 EPIDERMAL NECROSIS 1 0.0010
82 DILATED CARDIOMYOPATHY 1 0.0010
83 THROMBOPHLEBITIS SUPERFICIAL 3 0.0010
84 HYPOCHROMIC ANAEMIA 1 0.0010
85 EXTRAVASATION 4 0.0010
86 BLADDER DYSFUNCTION 1 0.0010
87 CEREBRAL ARTERY OCCLUSION 1 0.0009
88 RIGHT VENTRICULAR DYSFUNCTION 1 0.0009
89 POLYDACTYLY 1 0.0009
90 SENSE OF OPPRESSION 1 0.0008
91 RETINAL VASCULITIS 1 0.0008
92 STAPHYLOCOCCAL SKIN INFECTION 1 0.0008
93 AMPUTATION 1 0.0008
94 PHLEBITIS 4 0.0008
95 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 8 0.0008
96 RADICULOPATHY 2 0.0008
97 SKIN DEPIGMENTATION 1 0.0007
98 PROCTITIS 2 0.0007
99 GENITAL RASH 1 0.0007
100 PELVIC VENOUS THROMBOSIS 1 0.0007
101 POST HERPETIC NEURALGIA 1 0.0007
102 STRESS CARDIOMYOPATHY 4 0.0007
103 ACUTE ABDOMEN 1 0.0007
104 PORTAL HYPERTENSION 2 0.0006
105 INJECTION SITE DISCOLOURATION 8 0.0006
106 ONYCHOLYSIS 1 0.0006
107 HYPOVOLAEMIC SHOCK 3 0.0006
108 INJECTION SITE INFECTION 2 0.0006
109 INJECTION RELATED REACTION 1 0.0006
110 LEFT VENTRICULAR DYSFUNCTION 4 0.0006
111 BILIARY DYSKINESIA 1 0.0006
112 TENDERNESS 6 0.0006
113 SPLENIC INFARCTION 1 0.0006
114 THROMBOPHLEBITIS 2 0.0006
115 PANCREATIC FAILURE 1 0.0006
116 SKIN HYPOPIGMENTATION 1 0.0006
117 INDURATION 1 0.0006
118 PARAPARESIS 1 0.0006
119 MONOPARESIS 1 0.0006
120 NECROSIS 3 0.0005
121 DEEP VEIN THROMBOSIS 35 0.0005
122 INJECTION SITE CELLULITIS 1 0.0005
123 CHRONIC SINUSITIS 2 0.0005
124 PURULENCE 1 0.0005
125 VENOUS THROMBOSIS 2 0.0005
126 COLOSTOMY 1 0.0005
127 ULCER 8 0.0005
128 ANORECTAL DISORDER 1 0.0005
129 PERIPHERAL ISCHAEMIA 2 0.0005
130 PERIPHERAL VENOUS DISEASE 2 0.0005
131 DERMATITIS PSORIASIFORM 1 0.0005
132 VENOUS THROMBOSIS LIMB 1 0.0005
133 SKIN INDURATION 1 0.0005
134 PETECHIAE 5 0.0005
135 LIVEDO RETICULARIS 1 0.0005
136 ABNORMAL SENSATION IN EYE 2 0.0005
137 LIMB MASS 1 0.0005
138 PURPURA 4 0.0005
139 PRODUCT PACKAGE ASSOCIATED INJURY 1 0.0004
140 ISCHAEMIC STROKE 8 0.0004
141 GASTROINTESTINAL HYPOMOTILITY 1 0.0004
142 ISCHAEMIA 2 0.0004
143 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 1 0.0004
144 PULMONARY INFARCTION 1 0.0004
145 HYPOCALCAEMIA 8 0.0004
146 PUSTULE 1 0.0004
147 URINARY TRACT OBSTRUCTION 1 0.0004
148 PULSE ABSENT 2 0.0004
149 PARAESTHESIA ORAL 6 0.0004
150 SKIN DISCOLOURATION 19 0.0004
151 BRONCHITIS CHRONIC 1 0.0004
152 INJECTION SITE URTICARIA 10 0.0004
153 METASTASES TO PERITONEUM 1 0.0004
154 NODULE 5 0.0004
155 HYPERSENSITIVITY VASCULITIS 1 0.0004
156 PROTEIN TOTAL INCREASED 1 0.0004
157 TEMPOROMANDIBULAR JOINT SYNDROME 1 0.0004
158 MIGRAINE WITH AURA 1 0.0004
159 APHASIA 11 0.0004
160 RASH MACULO-PAPULAR 8 0.0004
161 PARAPLEGIA 1 0.0003
162 GASTROINTESTINAL NECROSIS 1 0.0003
163 HYPERCAPNIA 1 0.0003
164 INJECTION SITE VESICLES 2 0.0003
165 MENISCUS INJURY 2 0.0003
166 BLOOD BLISTER 1 0.0003
167 SWELLING OF EYELID 2 0.0003
168 PNEUMONIA VIRAL 1 0.0003
169 SKIN ULCER 8 0.0003
170 COLITIS ISCHAEMIC 2 0.0003
171 HEMIPARESIS 5 0.0003
172 B-CELL LYMPHOMA 1 0.0003
173 ECCHYMOSIS 2 0.0003
174 PUSTULAR PSORIASIS 1 0.0003
175 HYPOPNOEA 1 0.0003
176 ERYTHEMA NODOSUM 1 0.0003
177 TYPE I HYPERSENSITIVITY 1 0.0003
178 FACIAL PARESIS 1 0.0003
179 HYPERTHYROIDISM 4 0.0003
180 HYPOKINESIA 4 0.0003
181 PARADOXICAL DRUG REACTION 1 0.0003
182 NEURODERMATITIS 1 0.0003
183 PEMPHIGOID 2 0.0003
184 COLITIS 10 0.0003
185 SCAB 3 0.0003
186 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 1 0.0003
187 SWELLING 24 0.0003
188 PROCEDURAL HAEMORRHAGE 1 0.0003
189 NAIL DISCOLOURATION 1 0.0003
190 MACULAR DEGENERATION 3 0.0003
191 ARTERIOSPASM CORONARY 1 0.0002
192 INJECTION SITE WARMTH 5 0.0002
193 LEG AMPUTATION 1 0.0002
194 PULSELESS ELECTRICAL ACTIVITY 1 0.0002
195 DERMATITIS ALLERGIC 3 0.0002
196 LIP OEDEMA 1 0.0002
197 BUNDLE BRANCH BLOCK LEFT 1 0.0002
198 HEPATIC PAIN 1 0.0002
199 SKIN HYPERPIGMENTATION 2 0.0002
200 INJECTION SITE INDURATION 3 0.0002
201 OROPHARYNGEAL DISCOMFORT 2 0.0002
202 PERIPHERAL COLDNESS 3 0.0002
203 IMMUNE THROMBOCYTOPENIA 1 0.0002
204 SKIN ABRASION 1 0.0002
205 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 2 0.0002
206 DIABETIC NEUROPATHY 1 0.0002
207 INFLAMMATORY MARKER INCREASED 1 0.0002
208 INJECTION SITE INFLAMMATION 1 0.0002
209 HYPOAESTHESIA ORAL 3 0.0002
210 VAGINAL DISCHARGE 2 0.0002
211 FEMORAL NECK FRACTURE 1 0.0002
212 TRISMUS 1 0.0002
213 VARICOSE VEIN 1 0.0002
214 HAEMATOMA 5 0.0002
215 FOETAL DEATH 1 0.0002
216 PARTIAL SEIZURES 1 0.0002
217 PULMONARY EMBOLISM 18 0.0002
218 INTESTINAL RESECTION 1 0.0002
219 NORMAL NEWBORN 1 0.0002
220 NONSPECIFIC REACTION 1 0.0002
221 VERTIGO 11 0.0002
222 INJECTION SITE INJURY 1 0.0002
223 NERVE INJURY 2 0.0002
224 WOUND 5 0.0002
225 BLISTER 10 0.0002
226 REBOUND EFFECT 2 0.0002
227 SKIN WARM 1 0.0002
228 PERIPHERAL SENSORY NEUROPATHY 1 0.0002
229 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0002
230 HYPERCALCAEMIA 2 0.0002
231 PIGMENTATION DISORDER 1 0.0002
232 LIMB DISCOMFORT 5 0.0002
233 CHOLANGITIS 1 0.0002
234 BLEPHAROSPASM 1 0.0002
235 OCCUPATIONAL EXPOSURE TO PRODUCT 1 0.0002
236 ANAPHYLACTIC SHOCK 4 0.0002
237 CARDIAC FLUTTER 1 0.0002
238 INCOHERENT 1 0.0002
239 HERPES SIMPLEX 1 0.0002
240 TENDON DISORDER 1 0.0002
241 ORAL CANDIDIASIS 2 0.0002
242 PRESCRIBED UNDERDOSE 3 0.0002
243 EYE MOVEMENT DISORDER 1 0.0001
244 COORDINATION ABNORMAL 2 0.0001
245 BURNING SENSATION 10 0.0001
246 SKIN REACTION 2 0.0001
247 THERMAL BURN 1 0.0001
248 DERMATITIS BULLOUS 1 0.0001
249 MOUTH HAEMORRHAGE 1 0.0001
250 URTICARIA 22 0.0001
251 BOWEL MOVEMENT IRREGULARITY 1 0.0001
252 TENDONITIS 2 0.0001
253 ERYTHEMA 26 0.0001
254 POST PROCEDURAL INFECTION 1 0.0001
255 ACUTE CORONARY SYNDROME 1 0.0001
256 EMBOLISM 1 0.0001
257 HEMIPLEGIA 1 0.0001
258 SKIN PLAQUE 1 0.0001
259 CIRCULATORY COLLAPSE 2 0.0001
260 FACIAL PARALYSIS 1 0.0001
261 PRODUCT CONTAINER ISSUE 1 0.0001
262 RECTAL HAEMORRHAGE 5 0.0001
263 SKIN SWELLING 1 0.0001
264 URINE OUTPUT DECREASED 1 0.0001
265 GASTRITIS 3 0.0001
266 GROIN PAIN 1 0.0001
267 DRUG ERUPTION 2 0.0001
268 WRONG DRUG ADMINISTERED 1 0.0001
269 HAEMOLYTIC ANAEMIA 1 0.0001
270 OEDEMA 6 0.0001
271 CARDIAC ARREST 9 0.0001
272 BLOOD THYROID STIMULATING HORMONE INCREASED 1 0.0001
273 FLANK PAIN 1 0.0001
274 SQUAMOUS CELL CARCINOMA 1 0.0001
275 ABORTION INDUCED 1 0.0001
276 DIZZINESS POSTURAL 1 0.0001
277 HEPATOMEGALY 1 0.0001
278 TOXIC SKIN ERUPTION 1 0.0001
279 CELLULITIS 5 0.0001
280 MOTOR DYSFUNCTION 1 0.0001
281 NEUTROPHIL COUNT INCREASED 1 0.0001
282 INJECTION SITE ERYTHEMA 12 0.0001
283 DERMATITIS 2 0.0001
284 INCONTINENCE 1 0.0001
285 CONTUSION 9 0.0001
286 HYPERSENSITIVITY 17 0.0001
287 GASTROINTESTINAL PAIN 1 0.0001
288 ANAPHYLACTIC REACTION 5 0.0001
289 VENTRICULAR FIBRILLATION 1 0.0001
290 MALNUTRITION 1 0.0001
291 SNEEZING 2 0.0001
292 SKIN INFECTION 1 0.0001
293 PANCREATITIS ACUTE 2 0.0001
294 HYPOAESTHESIA 13 0.0001
295 EYELID OEDEMA 1 0.0001
296 RASH ERYTHEMATOUS 4 0.0001
297 PRESYNCOPE 2 0.0001
298 NEURALGIA 2 0.0001
299 INJECTION SITE MASS 3 0.0001
300 DYSGEUSIA 6 0.0001
301 CYST 1 0.0001
302 PEMPHIGUS 1 0.0001
303 SECRETION DISCHARGE 1 0.0001
304 INJECTION SITE IRRITATION 1 0.0001
305 INJECTION SITE SWELLING 6 0.0001
306 CHEST DISCOMFORT 8 0.0001
307 PAIN IN EXTREMITY 23 0.0001
308 PLATELET COUNT INCREASED 1 0.0001
309 IMMUNE SYSTEM DISORDER 1 0.0001
310 INJECTION SITE PAIN 23 0.0001
311 FREQUENT BOWEL MOVEMENTS 2 0.0001
312 UVEITIS 1 0.0001
313 PALLOR 2 0.0001
314 SKIN LESION 2 0.0001
315 PRURITUS 28 0.0001
316 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
317 APPLICATION SITE RASH 1 0.0001
318 RESPIRATORY DISTRESS 2 0.0001
319 PROCEDURAL PAIN 2 0.0001
320 CARDIO-RESPIRATORY ARREST 3 0.0001
321 MASS 1 0.0001
322 DISSEMINATED INTRAVASCULAR COAGULATION 1 0.0001
323 SINUS TACHYCARDIA 1 0.0001
324 INJECTION SITE HAEMATOMA 1 0.0001
325 LIVER FUNCTION TEST ABNORMAL 2 0.0001
326 PALPITATIONS 8 0.0001
327 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
328 TINNITUS 3 0.0001
329 DRUG ADMINISTRATION ERROR 2 0.0001
330 PHARYNGEAL OEDEMA 1 0.0001
331 HYPOTENSION 13 0.0001
332 CHEST PAIN 12 0.0001
333 BRAIN FOG 1 0.0001
334 CYANOSIS 1 0.0001
335 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
336 SENSORY DISTURBANCE 1 0.0001
337 HEART RATE INCREASED 6 0.0001
338 CHILLS 7 0.0001
339 PERICARDITIS 1 0.0001
340 TRANSIENT ISCHAEMIC ATTACK 2 0.0001
341 FLUSHING 6 0.0001
342 PERIPHERAL SWELLING 9 0.0001
343 RASH MACULAR 2 0.0001
344 HYPERKALAEMIA 2 0.0001
345 HYPOXIA 2 0.0001
346 PANCREATITIS 3 0.0001
347 COLD SWEAT 1 0.0001
348 LYMPHOCYTE COUNT DECREASED 1 0.0001
349 BRADYCARDIA 3 0.0001
350 GASTROENTERITIS VIRAL 1 0.0001
351 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
352 ADVERSE EVENT 5 0.0001
353 HEPATIC STEATOSIS 1 0.0001
354 TUBULOINTERSTITIAL NEPHRITIS 1 0.0001
355 PHOTOPHOBIA 1 0.0001
356 DYSARTHRIA 2 0.0001
357 GASTRIC ULCER 1 0.0001
358 PROTEINURIA 1 0.0001
359 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
360 PARAESTHESIA 8 0.0001
361 BLOOD PRESSURE ABNORMAL 1 0.0001
362 INJECTION SITE BRUISING 4 0.0001
363 CYTOKINE RELEASE SYNDROME 1 0.0000
364 PRODUCT ADMINISTRATION ERROR 1 0.0000
365 THERAPEUTIC RESPONSE DECREASED 3 0.0000
366 FEELING HOT 3 0.0000
367 DIZZINESS 24 0.0000
368 PRURITUS GENERALISED 1 0.0000
369 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
370 FAECES DISCOLOURED 1 0.0000
371 SEPTIC SHOCK 2 0.0000
372 PAIN 28 0.0000
373 APPLICATION SITE PAIN 1 0.0000
374 BLOOD PRESSURE DECREASED 3 0.0000
375 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1 0.0000
376 TACHYCARDIA 4 0.0000
377 STEVENS-JOHNSON SYNDROME 1 0.0000
378 TRANSAMINASES INCREASED 1 0.0000
379 TOOTH DISORDER 1 0.0000
380 COLITIS ULCERATIVE 2 0.0000
381 RASH PAPULAR 1 0.0000
382 SKIN IRRITATION 2 0.0000
383 PYREXIA 15 0.0000
384 HYPERTENSION 9 0.0000
385 ARRHYTHMIA 2 0.0000
386 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 3 0.0000
387 CEREBRAL INFARCTION 1 0.0000
388 DYSPEPSIA 4 0.0000
389 ABASIA 1 0.0000
390 EXTRAPYRAMIDAL DISORDER 1 0.0000
391 PNEUMONIA ASPIRATION 1 0.0000
392 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
393 ABDOMINAL PAIN LOWER 1 0.0000
394 HEPATITIS 1 0.0000
395 LOSS OF CONSCIOUSNESS 5 0.0000
396 RASH GENERALISED 1 0.0000
397 DEAFNESS 1 0.0000
398 SPEECH DISORDER 2 0.0000
399 JAUNDICE 1 0.0000
400 PAIN OF SKIN 1 0.0000
401 BLOOD BILIRUBIN INCREASED 1 0.0000
402 PNEUMONITIS 1 0.0000
403 VISION BLURRED 5 0.0000
404 HAEMATOCHEZIA 2 0.0000
405 PANCYTOPENIA 2 0.0000
406 RENAL IMPAIRMENT 3 0.0000
407 ANGINA PECTORIS 1 0.0000
408 HYPERSOMNIA 1 0.0000
409 DECREASED APPETITE 8 0.0000
410 RASH 15 0.0000
411 DYSSTASIA 1 0.0000
412 MUSCULOSKELETAL STIFFNESS 3 0.0000
413 ASCITES 1 0.0000
414 ACUTE MYOCARDIAL INFARCTION 1 0.0000
415 ADVERSE DRUG REACTION 3 0.0000
416 FEELING ABNORMAL 8 0.0000
417 FALL 11 0.0000
418 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
419 EPILEPSY 1 0.0000
420 EXPOSURE DURING PREGNANCY 2 0.0000
421 SWOLLEN TONGUE 1 0.0000
422 MALAISE 14 0.0000
423 OFF LABEL USE 27 0.0000
424 CHOLELITHIASIS 1 0.0000
425 IMPAIRED HEALING 1 0.0000
426 OSTEONECROSIS 1 0.0000
427 INFUSION RELATED REACTION 2 0.0000
428 EXPIRED PRODUCT ADMINISTERED 1 0.0000
429 LIP SWELLING 1 0.0000
430 DEHYDRATION 4 0.0000
431 SYNCOPE 3 0.0000
432 SKIN DISORDER 1 0.0000
433 GAIT INABILITY 1 0.0000
434 INJECTION SITE PRURITUS 2 0.0000
435 HAEMATURIA 1 0.0000
436 GASTRIC DISORDER 1 0.0000
437 INJECTION SITE REACTION 2 0.0000
438 LYMPHADENOPATHY 1 0.0000
439 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
440 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
441 NAUSEA 22 0.0000
442 WRONG TECHNIQUE IN DRUG USAGE PROCESS 1 0.0000
443 C-REACTIVE PROTEIN INCREASED 1 0.0000
444 HYPERGLYCAEMIA 1 0.0000
445 ASTHENIA 10 0.0000
446 UNEVALUABLE EVENT 2 0.0000
447 ACNE 2 0.0000
448 GAIT DISTURBANCE 5 0.0000
449 VOMITING 12 0.0000
450 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
451 DRUG INTERACTION 4 0.0000
452 PSORIATIC ARTHROPATHY 1 0.0000
453 FOETAL EXPOSURE DURING PREGNANCY 2 0.0000
454 BLINDNESS 1 0.0000
455 INFLUENZA LIKE ILLNESS 2 0.0000
456 PRODUCT USE IN UNAPPROVED INDICATION 6 0.0000
457 HEADACHE 15 0.0000
458 SKIN EXFOLIATION 2 0.0000
459 MENTAL DISORDER 1 0.0000
460 ANGIOEDEMA 1 0.0000
461 THROAT IRRITATION 1 0.0000
462 THERAPY NON-RESPONDER 1 0.0000
463 HYPOKALAEMIA 1 0.0000
464 OCULAR HYPERAEMIA 1 0.0000
465 COMA 1 0.0000
466 MIGRAINE 2 0.0000
467 ATRIAL FIBRILLATION 2 0.0000
468 DYSPNOEA 11 0.0000
469 ACCIDENTAL EXPOSURE TO PRODUCT 2 0.0000
470 FATIGUE 15 0.0000
471 ABDOMINAL DISTENSION 2 0.0000
472 ECZEMA 1 0.0000
473 DEPRESSED MOOD 1 0.0000
474 CONFUSIONAL STATE 3 0.0000
475 OVERDOSE 4 0.0000
476 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
477 ASTHMA 2 0.0000
478 HERPES ZOSTER 1 0.0000
479 EYE IRRITATION 1 0.0000
480 GENERAL PHYSICAL HEALTH DETERIORATION 2 0.0000
481 BACK PAIN 4 0.0000
482 ABDOMINAL PAIN 4 0.0000
483 BONE PAIN 1 0.0000
484 CATARACT 1 0.0000
485 OEDEMA PERIPHERAL 2 0.0000
486 DISCOMFORT 1 0.0000
487 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
488 VISUAL IMPAIRMENT 2 0.0000
489 AMNESIA 1 0.0000
490 SWELLING FACE 1 0.0000
491 PSORIASIS 2 0.0000
492 DRUG INEFFECTIVE 20 0.0000
493 WEIGHT DECREASED 4 0.0000
494 DIARRHOEA 9 0.0000
495 INFECTION 2 0.0000
496 AGITATION 1 0.0000
497 EPISTAXIS 1 0.0000
498 DIABETES MELLITUS 1 0.0000
499 ARTHRITIS 1 0.0000
500 THROMBOSIS 1 0.0000
501 ARTHRALGIA 5 0.0000
502 MYOCARDIAL INFARCTION 2 0.0000
503 COUGH 3 0.0000
504 PRODUCT USE ISSUE 2 0.0000
505 NEUROPATHY PERIPHERAL 1 0.0000
506 ANAEMIA 2 0.0000
507 SOMNOLENCE 2 0.0000
508 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2 0.0000
509 CONDITION AGGRAVATED 3 0.0000
510 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
511 HAEMOGLOBIN DECREASED 1 0.0000
512 ABDOMINAL PAIN UPPER 2 0.0000
513 PLATELET COUNT DECREASED 1 0.0000
514 CONSTIPATION 2 0.0000
515 SEPSIS 1 0.0000
516 JOINT SWELLING 1 0.0000
517 HYPERHIDROSIS 1 0.0000
518 RENAL FAILURE 1 0.0000
519 INSOMNIA 2 0.0000
520 MEMORY IMPAIRMENT 1 0.0000
521 ACUTE KIDNEY INJURY 1 0.0000
522 PNEUMONIA 2 0.0000
523 TREMOR 1 0.0000
524 TOXICITY TO VARIOUS AGENTS 1 0.0000
525 CEREBROVASCULAR ACCIDENT 1 0.0000
526 MYALGIA 1 0.0000
527 URINARY TRACT INFECTION 1 0.0000
528 WEIGHT INCREASED 1 0.0000
529 DEPRESSION 1 0.0000
530 DEATH 1 0.0000